Alternatives to Oncora

Carevive provides a cancer care management platform that is integrated with electronic health records (EHR) to improve patient outcomes across the entire cancer treatment process. This innovative platform streamlines treatment planning by gathering patient preferences, evaluating interests in clinical trials, and tackling both physical and psychosocial challenges to enhance decision-making processes. During the active treatment phase, Carevive supports remote monitoring of symptoms through electronic patient-reported outcomes (ePROs), offering personalized symptom management plans and evidence-based pathways that aim to elevate quality of life and minimize hospital admissions. After treatment concludes, the platform continues to monitor patient-reported late effects and organizes essential care, which includes diagnostic assessments to identify new or recurring cancers. Furthermore, Carevive's analytics provide insights into aggregated patient experience data, aiding in ongoing quality enhancement and contributing to practical research in oncology. This comprehensive approach ensures that patients receive holistic support throughout their cancer journey, ultimately leading to better health outcomes.

Numerous choices in cancer treatment are fraught with uncertainty, and existing resources fail to assist a significant number of patients effectively. As a result, this situation contributes to preventable fatalities and the loss of billions in healthcare expenditures. Our team, which consists of experts from both computer science and oncology, is dedicated to addressing the critical challenges in cancer care using artificial intelligence. We are developing clinical-grade deep learning models that evaluate individual patient profiles and offer valuable guidance to oncologists during their decision-making processes. By placing oncologists at the forefront of our AI development, we ensure that the insights generated are not only interpretable but also actionable. Collaborating with leading academic medical institutions and community oncologists, we aim to tackle important clinical questions to improve patient outcomes. Ultimately, our goal is to enhance decision-making in cancer care and reduce the associated burdens on patients and healthcare systems.

Volpara Health software is utilized by various facilities, including leading cancer screening centers in the United States, to facilitate the early detection of breast cancer. Mammography technologists depend on this software to enhance the quality of mammograms. Recognized as the most scientifically validated screening tool in the breast health sector, Volpara provides essential evidence at critical moments. It offers access to comprehensive patient data, enabling more accurate assessments of breast cancer risk. Each analyzed image contributes to refining our algorithms for early detection of the disease. Your support is crucial in promoting additional screening or genetic tests for patients. The platform allows for the creation of tailored worklists and reports according to individual preferences. Users can simultaneously view statistics and lists from a single interface, making the process more efficient. Communication can be standardized across patients, referrers, and insurers, ensuring clarity and consistency. Furthermore, it enhances the delivery of result letters by incorporating thumbnail images of mammograms, making the information more engaging and informative. This multifaceted approach ultimately promotes better patient care and outcomes in breast health.

Omda Cytodose, an oncology medication management solution from Omda, employs clinically validated protocols along with patient-specific parameters to ensure safer and more effective treatments for individuals battling cancer. This innovative system enhances the quality of care provided to oncology patients by fostering a seamless and collaborative treatment process among healthcare professionals, including doctors, pharmacists, and nurses. Omda Cytodose is designed to support a comprehensive range of adult and pediatric cancers, accommodating various medical treatments such as chemotherapy, immunotherapy, hormone therapy, and additional supportive medications. Initially created by a team of clinicians at one of Norway's premier cancer centers and introduced in 2001, Omda Cytodose has gained widespread adoption across healthcare regions in the Nordic countries, leading to the fulfillment of millions of medication orders. With a robust 15-year history marked by stability, reliability, and safety, the system is meticulously configured with chemotherapy protocols that reflect both national and international guidelines. This ensures that patients receive the most up-to-date treatment options available, further enhancing their chances of successful outcomes.

AI plays a crucial role in identifying early-stage cancers, facilitating prompt interventions that enhance survival prospects. Cancer's intricate nature means that each type carries distinct characteristics, packed with extensive data that requires thorough analysis. This is where AI excels, leveraging its capabilities to process complex information, ultimately revealing insights that can significantly aid in cancer treatment strategies. Equipped with precise and relevant data, we take proactive steps in our battle against cancer. By utilizing AI, we are poised to make substantial strides in overcoming this disease. Our AI technology is designed to detect early-stage cancer with remarkable accuracy, achieving detection rates between 97-99%. It proficiently identifies ten of the most prevalent abnormalities found in chest x-rays, thus enhancing one of the most fundamental diagnostic tools. This innovation not only streamlines the radiology workflow but also alleviates the workload for radiologists. Lunit INSIGHT CXR successfully encompasses a wide range of findings, ensuring that we are prepared to tackle the challenges presented by cancer detection and treatment. The future of cancer care looks promising with AI at the forefront of these advancements.

Ibex Medical Analytics stands at the forefront of AI-driven cancer diagnostics within the field of pathology. Our diverse team comprises entrepreneurs, data scientists, software engineers, and medical professionals united in our mission to revolutionize cancer diagnostics through artificial intelligence, ultimately enhancing patient care. As the volume of tests continues to rise annually, pathologists face significant challenges in delivering precise and timely analyses. To address this, Ibex harnesses the power of AI to create clinical-grade solutions that aim to identify cancer with the same level of accuracy as a human pathologist. The Galen Platform employs advanced algorithms to scrutinize images, detect and classify cancer in biopsy samples, and highlight other clinically significant findings, thereby assisting pathologists in minimizing diagnostic errors while streamlining their workflow. Notably, Ibex’s Galen™ Prostate and Galen™ Breast solutions represent the pioneering AI-based cancer detection tools integrated into routine clinical practice in pathology labs, showcasing proven efficacy in uncovering previously missed cancer cases. As we continue to innovate, our commitment to improving cancer detection and patient outcomes remains unwavering.

Accelerating the speed, precision, and affordability of cancer diagnoses is crucial, especially considering that one in three individuals will face this disease in their lifetime. Unfortunately, the current diagnostic process is often hindered by slow and costly methods, primarily due to the lack of advanced automated tools that support healthcare professionals. Qritive addresses this challenge by offering an AI-driven solution designed to assist physicians in analyzing both microscopy images and textual patient data efficiently. This innovation not only enhances the effectiveness of hospitals in diagnosing cancer but also contributes to significant cost savings. Additionally, Pantheon serves as a CE-marked, vendor-agnostic digital pathology platform that facilitates the complete digitization of pathology lab workflows and telepathology. It also supports comprehensive report generation and offers a robust platform for AI-driven analysis of whole-slide images in pathology. This technology is particularly adept at distinguishing between a variety of benign conditions and malignant diseases within breast tissue, which is vital for timely and accurate treatment. In doing so, it plays a pivotal role in transforming the landscape of cancer diagnostics.

Noona® offers a comprehensive management solution for patient outcomes that actively involves patients in their treatment through immediate symptom reporting and monitoring, enhanced clinical workflows that support evidence-based practices, and access to extensive data insights for improved ongoing care management. Patients have the freedom to report their symptoms, fill out questionnaires, and engage with their healthcare teams whenever they wish. This approach enables care teams to gather highly specific and detailed data tailored to each patient's diagnosis and treatment plan, facilitating better-informed decision-making. With the benefit of automated prioritization, healthcare providers can identify and respond to patients who require urgent attention. The platform features over 31 treatment modules that encompass more than 97 prevalent cancer types, complemented by 244 algorithms that assess symptom severity according to established guidelines. Additionally, its remote deployment capabilities ensure quick implementation and immediate access for patients to start using the system. This innovative solution ultimately enhances the overall quality of patient care and outcomes throughout the treatment journey.

Aiforia provides advanced deep learning and cloud-based solutions to pathologists and researchers in both preclinical and clinical laboratories, enhancing their capabilities in image analysis and workflow efficiency. By enabling scientists to discover new disease biomarkers and assisting R&D professionals in accelerating the market introduction of innovative drugs, Aiforia plays a crucial role in improving cancer diagnostic accuracy while revolutionizing healthcare from the initial discovery phase through to diagnosis. For clinical pathology laboratories seeking to boost efficiency and elevate the precision of their diagnoses, the Aiforia Clinical Suites present a comprehensive range of AI-driven diagnostic tools, intelligent visualization, quality control, and automated pre- and post-screening functionalities. We are in the process of developing specialized Suites targeting some of the most common cancers globally and have achieved CE-IVD certification for our AI solutions in lung and breast cancer, positioning us as a leader in diagnostic innovation. Our commitment to enhancing patient outcomes through technology underscores the transformative potential of our offerings in the healthcare sector.

Mamosis offers a cutting-edge AI-powered cancer diagnosis solution that accelerates and improves diagnostic accuracy by analyzing complex medical images and wellness metrics. The platform’s deep learning algorithms, developed with input from clinical experts, identify subtle patterns and anomalies that aid in early cancer detection. Mamosis delivers detailed, easy-to-interpret reports quickly, allowing clinicians to initiate timely interventions. The user-friendly interface streamlines the diagnostic process, enabling secure uploads and fast analysis, saving valuable time in clinical settings. With stringent data encryption and privacy protocols, patient information is protected at every step. Mamosis not only aids medical professionals but also empowers individuals by providing personalized health insights for proactive wellness management. The software integrates seamlessly into existing workflows, enhancing efficiency without disrupting daily operations. By fostering collaboration between AI and human expertise, Mamosis drives more accurate diagnoses and improved patient care.

The product evaluates a patient's risk level to create a tailored digital screening plan, ensuring more reliable follow-up recommendations and enhancing diagnostic accuracy. This strategy is particularly effective in identifying cancers in women who are at heightened risk. WRRisk integrates a fully digital breast cancer risk assessment that utilizes patient-completed digital forms alongside a density evaluation to generate a comprehensive risk scorecard. By automating numerous manual processes, such as form collection and letter creation, WRRisk streamlines the management of breast risk programs, eliminating the need for paper documentation. This innovative product empowers both patients and healthcare providers with essential information, enhancing the overall care experience. Additionally, WRRisk provides calculations for ten-year and lifetime risk, as well as assessments based on secondary density metrics.

Enhance the effectiveness and efficiency of cancer care throughout various healthcare environments. Developed in close partnership with cancer specialists, iKnowMedSM serves as an electronic health record (EHR) that seamlessly offers essential patient information precisely when it’s needed, accessible on nearly any device. Featuring the latest advancements in user interface design and an unparalleled mobile platform, iKnowMed EHR delivers extensive point-of-care treatment decision support alongside customizable features that easily fit into current workflows. Empower your patients with thorough clinical assistance by utilizing a constantly refreshed repository of oncology treatment protocols, drug availability, and clinical outcomes. Gain access to evidence-based clinical guidelines and pathways precisely when required, ensuring timely and effective decision-making. Furthermore, keep your treatment options current by integrating data on treatment expenses, insurance coverage, and reimbursement information, thereby supporting both patients and healthcare providers in navigating the complexities of cancer treatment. In doing so, practices can significantly improve patient outcomes and streamline the overall care process.

No matter the scale of your clinic or your location, MOSAIQ Plaza* equips you with the essential digital tools to provide exceptional multidisciplinary care for your patients—ensuring consistency, reliability, and security throughout their journey from diagnosis to survivorship while generating valuable real-world evidence. Elekta has introduced robust solution packages designed to boost your team's ability to provide care and optimize treatment workflows, allowing you to concentrate on your primary focus: your patients. As we pave the way for the future of multidisciplinary cancer care, MOSAIQ 3 establishes new benchmarks in oncology workflow and information management. Experience the advantages of effortless access to the MOSAIQ Plaza environment, which leads to remarkable efficiencies and a more streamlined operational experience, ultimately enhancing patient outcomes and satisfaction.

Speeding up the creation of crucial medications and ensuring that patients worldwide can access top-notch cancer treatment and research equally. Our technology is transforming how patients access cutting-edge medicines and participate in clinical trials. FICS is a groundbreaking software solution that facilitates the gathering of regulatory-compliant data throughout patient treatment. By integrating previously isolated and non-interacting applications into a comprehensive, seamless platform, FICS is making clinical trials more efficient, quicker, and of superior quality, ultimately enhancing patient outcomes in significant ways.

Explore our efficient screening tools designed to identify patients at a high risk for breast, colorectal, and other types of cancer. Progeny Clinical streamlines the management of family histories, risk assessments, and treatment options for your patients. You can gather family history information online and automatically create pedigrees prior to the clinic appointment. Modify existing pedigrees or create new ones at any time. Execute validated hereditary cancer risk assessment models with a single click, eliminating the need to re-enter data. Simplify the process by ordering genetic testing through Ambry Genetics. Monitor and analyze results from any laboratory without leaving the software environment. Enhance efficiency by generating letters, consultation notes, reports, and documents using custom templates that incorporate patient data fields. Utilize pre-configured or tailored data input screens to swiftly create custom queries and spreadsheet reports. Moreover, you can integrate a hyperlink within your electronic medical record to conveniently access the patient’s latest pedigree. This innovative approach not only saves time but also optimizes patient care and enhances workflow efficiency.

Enhance the Patient Journey by actively engaging, educating, and empowering individuals through improved health communications. Utilize a Patient Engagement Platform to tailor optimal care plans for various medical pathways, such as prostate and breast cancer. Develop a Patient Engagement Pathway that organizes communication strategies in accordance with each care plan's requirements. Streamline the organization of communications by creating or sourcing a variety of supportive materials, including messages, documents, and videos, that correspond to different phases of the care plan. Establish clear communication rules that specify who receives which communications and at what times, ensuring timely delivery of essential information. Integrate new patients into the system effortlessly by matching their specific needs with the appropriate pathway. Finally, centralize all patient-facing communications in one location, allowing for the efficient dissemination of messages, documents, forms, videos, and health widgets. By doing so, healthcare providers can enhance the overall patient experience and foster better health outcomes.

My Care PlusSM enhances the healthcare experience by fostering a personal connection that allows patients to take charge of their health journey. Through the user-friendly portal, individuals can easily access their personal health records, communicate with their healthcare providers, and explore a newly expanded repository of educational resources designed for patients. Patients are granted the ability to review their comprehensive care plans, along with vital health information and educational materials on conditions and medications sourced from reputable cancer organizations, accessible at any time and from any location. They can also utilize secure messaging to address non-urgent inquiries or send broadcast messages to all patients, ensuring effective communication. To boost patient engagement with the portal, customizable marketing resources, videos, and other tools are available to raise awareness of its advantages. Additionally, the platform supports healthcare practices in achieving Meaningful Use objectives by integrating all necessary features to fulfill both stage 1 and stage 2 requirements. Furthermore, it offers robust clinical decision support, along with performance analytics to enhance practice efficiency and patient care. With this comprehensive suite of services, My Care PlusSM not only improves patient interactions but also enhances the overall quality of care provided.

CureMetrix harnesses the capabilities of Artificial Intelligence (AI) to enhance technology aimed at bettering disease detection and boosting cancer survival rates on a global scale. Our mission is centered on equipping radiologists with state-of-the-art tools that facilitate their assessment of mammograms, ultimately leading to enhanced clinical and financial results, as well as greater confidence for imaging centers, healthcare systems, and the patients they serve. Initial research involving thousands of images indicates that our innovative algorithm has the potential to decrease false-positive rates, which can help avoid unnecessary follow-up procedures and alleviate patient anxiety. We are committed to creating advanced technology that allows healthcare providers to detect even the smallest changes more swiftly and accurately than ever before. Our image analysis platform is specifically engineered to enhance the evaluation of dense breast tissue through mammography, thereby improving diagnostic accuracy and patient care. As we continue to refine our technology, we remain focused on the impact it can have on the future of medical imaging and patient outcomes.

Color delivers one of the most user-friendly, high-quality genetic testing services currently on the market, examining genetic markers linked to the likelihood of developing prevalent cancers and heart diseases, as well as how individuals metabolize specific medications. Our comprehensive range of services, tools, and expertise is designed to facilitate the enrollment of new patients and guide them through personalized care journeys that evolve over time. By taking a holistic approach to patient health, we integrate genetic data, personal and family medical histories, along with lifestyle and behavioral factors to identify and suggest tailored care options or solutions that align with each patient's unique risk profile. This multifaceted strategy ensures that patients receive relevant recommendations that can significantly impact their health outcomes.

The ARIA® oncology information system is designed to assist both medical and radiation oncology practitioners, including those utilizing proton therapy. It enables the review of clinical images, prescriptions, lab results, quality assurance, treatment outcomes, and much more. Additionally, it automates cancer staging in accordance with AJCC guidelines and allows for flexible management of treatment toxicities. With a strong emphasis on interoperability, ARIA ensures that patient data can be utilized effectively across various devices and platforms. It provides comprehensive support for HL7 and DICOM standards, simplifying the transfer of patient data between healthcare facilities. This system grants your teams immediate access to patient information, enhancing their ability to plan and make real-time adjustments as needed. Furthermore, ARIA OIS aids in optimizing image-guided treatment techniques by utilizing radiographic, fluoroscopic, and cone-beam CT images. It also documents activities to support evidence-based Pay-for-Performance initiatives while ensuring compliance with HIPAA regulations. By efficiently storing and organizing patient data and images, ARIA enables your teams to remain informed and dedicated to providing high-quality care for their patients. This innovative system ultimately streamlines workflows, allowing healthcare providers to focus on what truly matters: patient outcomes and well-being.

Complion's platform was designed for clinical researchers. Our solution ensures compliance at the highest level with the lowest effort and the most efficiency. This allows you to concentrate on what really matters: improving and advancing patient outcomes. Our eReg solution is available to all clinical trial stakeholders, whether you are a Sponsor, Research Site or CRO. Reduce costs, avoid redundancy and increase staff productivity. You can easily archive, view and get signatures from any device. An audit trail is built into the system to ensure accuracy and eliminate patient safety risks and study conduct. Our clients include hospitals, cancer centers, and medical centers as well as multi-specialty clinics and dedicated research sites.

Concentriq, our advanced AI-driven software platform, operates at the crucial crossroads of digital and computational pathology, merging essential functionalities for routine pathology tasks with robust AI tools that enhance innovations and elevate patient care quality. Pathology laboratories around the globe are acutely aware of the contemporary hurdles, which include an escalating cancer incidence, a shortage of trained pathologists, diminishing reimbursement rates, and the urgent need for modernization. In this context, with one billion pathology slides projected to transition to digital formats annually, generating enormous volumes of new data and insights, the urgency to act is undeniable. Digital pathology equips today’s progressive pathology organizations with the resources necessary to tackle these challenges effectively, thereby revolutionizing our operational methods and significantly impacting the fields of medicine and patient treatment. As this transformation unfolds, the potential for improved diagnostics and enhanced patient outcomes continues to grow exponentially.

Qure.ai's qLC-Suite is a cutting-edge AI-driven tool aimed at improving the early identification and management of lung nodules, which is crucial for prompt lung cancer intervention. This solution delivers accurate measurements, thorough characterization, and 3D imaging of lung nodules, ensuring that opportunities for early treatment are not overlooked. It is capable of supporting both incidental and targeted screenings by efficiently identifying nodules and calculating their volume with just one click. Moreover, the system monitors volumetric changes over time, providing valuable insights into nodule development. The qLC-Suite is designed to integrate smoothly into current workflows, offering quick analysis and reporting that assist healthcare professionals in their decision-making processes. In addition to its analytical capabilities, it serves as a comprehensive platform for managing lung nodules, facilitating care coordination through intelligent prompts, providing hardware-agnostic image viewing for AI-enhanced chest X-rays and CT scans, enabling seamless sharing of scans across departments, and allowing for tailored notifications for cases of concern. Overall, qLC-Suite represents a significant advancement in lung cancer care, promoting timely interventions that can ultimately save lives.

The integrated mammography viewer allows for ergonomic reading of a diverse range of breast imaging studies alongside other specialty examinations, all conveniently located in one interface. By streamlining workflows, it facilitates quicker reading in high-volume settings, resulting in increased patient throughput. The incorporation of Artificial Intelligence enhances physician efficiency, reduces false negatives in cancer detection, and contributes to the quality assurance of imaging results. A holistic telemammography solution serves as a vital link to expanding access to breast expertise, ultimately leading to improved diagnostic accuracy and patient outcomes. The NovaMG PRO can function as an independent workstation compatible with any PACS or mammography technology. Additionally, the breast care workflow module is included within NovaPACS EI, and current users can activate it in just a few minutes, enhancing their existing systems. This integration not only simplifies the process but also empowers healthcare professionals to deliver better care to patients.

ConcertAI stands out as a prominent provider of AI-driven solutions within the healthcare sector, particularly in the field of oncology. Their core mission revolves around enhancing patient outcomes and expediting insights by leveraging top-tier real-world data, cutting-edge AI technologies, and deep scientific knowledge. The company presents an array of products and services aimed at improving both clinical research and patient care experiences. Their Real-World Data Products deliver extensive, customized datasets that cater to diverse research needs across various enterprises. By simplifying clinical trial processes, their digital trial solution ensures efficiency, while the Clinical Trial Optimization (CTO) platform employs extensive AI capabilities to refine the design and implementation of trials specifically in oncology and hematology. Additionally, in partnership with NeoGenomics, ConcertAI has introduced CTO-H, a software-as-a-service (SaaS) solution that concentrates on hematological malignancies, providing sophisticated research analytics and optimizing operational workflows. This integration of advanced technologies not only enhances research capabilities but also significantly contributes to the advancement of patient care in complex medical fields.

Enable patients to seamlessly navigate their digital healthcare experiences. GYANT's AI-driven virtual assistant alleviates the burden on clinical staff and reduces operational costs while enhancing patient outcomes and satisfaction levels. We collaborate with hospitals, healthcare systems, and integrated delivery networks to implement our adaptable and tailored technology across various platforms, including websites, mobile applications, and patient portals. By guiding patients swiftly to both digital and in-person care options, this AI-enhanced solution works harmoniously with medical record systems and features advanced natural language processing capabilities. It not only offers educational resources but also provides a virtual triage system to evaluate risk, efficiently directing triaged patients to suitable telehealth services, nurse lines, or physical locations for necessary testing and treatment. Utilizing standardized medical protocols alongside our unique natural language processing framework, this innovative approach effectively gathers patient history, performs a review of systems, and automatically completes patient charts, ultimately contributing to the reduction of physician burnout and allowing healthcare professionals to focus more on patient care. Through this integration of technology, we aim to redefine the patient experience in healthcare settings.

Achieve a comprehensive understanding of your research operations by utilizing a robust and standardized clinical trial management system that has been developed in partnership with prominent academic medical and cancer centers. Streamline billing designation processes to promote uniformity across various teams and systems. Enhance your budgeting strategies, ensure accurate routing of charges, and perform more effective audits and monitoring of billing compliance. This integrated approach provides deep visibility and insight into all elements of clinical research, particularly in financial management, thanks to collaboration with elite research institutions. Moreover, by connecting OnCore with your existing electronic medical records (EMR), including seamless integrations with Epic and Cerner, you can significantly boost patient safety, minimize redundant data entry, improve billing compliance, and elevate overall operational efficiency. Ultimately, this system not only simplifies processes but also fosters a more effective research environment.

Efficiently generating reports for NGS-based clinical tests necessitates a well-established and sophisticated platform that can automatically prioritize variants, interpret clinical data, and create comprehensive reports. Strand Omics serves as a rapid, HIPAA-compliant cloud platform that enhances our clinical diagnostics efforts, having been refined over four years through the analysis of more than 10,000 clinical reports and numerous peer-reviewed studies. This platform integrates advanced bioinformatics algorithms with curated databases, intuitive visualization tools, and robust reporting features. It is designed with specialized workflows tailored for both rare inherited conditions and somatic tumor profiling assays. Additionally, the system boasts a library of over 10,000 somatic variants that have been curated for their oncogenic potential, alongside 100 genes selected for their druggability across various cancer types, as well as 500 drugs that have been validated for efficacy against multiple cancers. Furthermore, its comprehensive approach ensures that healthcare professionals have access to critical data, ultimately facilitating informed decision-making in patient care.

We assist in standardizing the contouring of organs at risk and automating segmentation in radiotherapy, which enhances the efficiency of cancer treatment planning. By adhering to established consensus guidelines, we ensure that the contours you create are more reliable. Every clinic requires a robust standard, and we take charge of implementing it on your behalf. Our fully automated 3D organ models can be generated in just a minute, significantly reducing the time spent on manual processes. This allows you to concentrate on more intricate delineation tasks rather than squandering valuable resources. Manual contouring often suffers from inter-observer variation, a challenge we address by providing consistent results. As a result, you can effectively reduce the negative consequences that stem from errors in the delineation of anatomical structures. With a single software solution that complies with GDPR regulations, the process of radiotherapy treatment planning has never been more straightforward. Our cloud-based AI model is designed to integrate effortlessly with all hospital systems, enhancing your workflow. MVision AI stands out as an innovative provider of cloud-based software services specifically for radiotherapy treatment planning, setting a new standard in the field. This approach not only improves accuracy but also promotes better patient outcomes in the long run.

Envision a transformative approach to care management that lowers healthcare expenses, reduces both admissions and readmissions, enhances star ratings and HEDIS metrics, and elevates health quality and outcomes through a mission-focused data platform driven by artificial intelligence. As the healthcare sector increasingly embraces value-based care, Health EM.AI emerges as a pioneer, redefining care management and enhancing care delivery through innovative data utilization and AI technology. By streamlining patient information from various care settings and leveraging AI/ML-driven predictive analytics, we equip healthcare organizations with actionable insights that significantly enhance care quality. Our approach ensures measurable improvements at the individual patient level, particularly within palliative and chronic care management workflows. The integration of unified patient 360 data across all care settings leads to meaningful advancements in star ratings, risk adjustment, and the effective closing of care gaps. Additionally, our localized healthcare models examine over 1,000 clinical and non-clinical variables based on geographical context, further refining the effectiveness of care. This comprehensive strategy not only fosters better patient outcomes but also encourages a more efficient healthcare ecosystem.

Our software products are crafted for simplicity and quick comprehension. User-friendly interfaces, developed in collaboration with Oncologists, are designed to maximize efficiency and save valuable time. We implement robust systems aimed at improving patient safety while introducing innovative modules that push the boundaries of research. Automation is at the heart of our solutions, facilitating everything from chemotherapy order planning to staff management. We provide a thorough solution tailored for cancer centers, optimizing the Oncology workflow seamlessly. With our platform, generating accurate chemotherapy orders is a swift and uncomplicated process. Our extensive protocol library boasts over 1000 regularly updated protocols. The system automatically calculates and confirms drug doses and infusion rates while being rigorously tested and CE marked for quality assurance. All doses are verified twice, and checks for drug-drug and drug-allergy interactions are included. Patient-drug matching is enhanced through QR coded labels, significantly reducing medication errors. Users can conveniently view the active chemotherapy order, patient diagnosis and stage, the latest lab results, and the chemotherapy flowsheet all on a single screen, ensuring a comprehensive overview at a glance. This streamlined approach promotes efficiency and safety in Oncology practice.

To enhance outcomes, it is essential to recognize the whole patient, empower both patients and their care teams, and promote the scalability and efficiency of care management programs. Optum® Patient Care Management enables organizations to proactively and intelligently oversee patient care throughout the healthcare ecosystem, forming sustainable networks that facilitate genuine patient-centered care at every phase of the patient experience. By establishing intelligent workflows, automatically triggering essential tasks, and creating precise interventions along with individualized care plans, Optum Patient Care Management allows care managers to concentrate on critical issues that significantly influence care quality and costs. Through the aggregation and normalization of diverse clinical and claims data, along with an expanding array of sociodemographic, behavioral, and patient-reported information, Optum can provide a comprehensive, 360-degree view of every patient for whom care coordination is being conducted. This holistic approach ensures that care is not only comprehensive but also tailored to meet the unique needs of each patient effectively.

Enhance your revenue in clinical research by pinpointing deficiencies in clinical care. CliniWorks’ AccelInsight™ Analytics Application facilitates Population Health Management through data-driven clinical decision-making, offering insightful reports and tools that reveal care gaps across various disease areas. With AccelInsight™, healthcare professionals can access customized, near-real-time analytics derived from extensive structured and unstructured datasets, including patient medical records and other sources, to uncover evidence-based opportunities for quality improvement, risk stratification, gap analysis, and effective care management. Additionally, AccelCare™ empowers healthcare providers to swiftly establish preferred intervention plans based on best-practice protocols, align patient cases from medical records with established medical guidelines and workflows, and trigger immediate corrective workflows alongside real-time alerts and information dissemination to quality assurance teams, management, and providers. This comprehensive approach not only enhances patient outcomes but also improves overall efficiency in healthcare delivery.

OM1 leverages artificial intelligence and extensive clinical data to significantly enhance research productivity and clinical decision-making via high-performance predictive models. The OM1 Patient Finder employs advanced AI technology seamlessly integrated with the OM1 Real-World Data Cloud. By merging various aspects of patient journeys from diverse data sources, it effectively identifies individuals most likely to be affected by the target condition. We have developed an intelligent data cloud that allows various healthcare stakeholders to access, analyze, and utilize outcomes data in a manner that is not only more comprehensive but also clinically relevant and precise. This enables rapid, accurate, and cost-effective access to research-grade insights regarding effectiveness, value, and safety. Moreover, it allows for the quantification of outcomes, facilitating the demonstration of value in risk-sharing and outcomes-based payment models. As a result, healthcare providers can make informed decisions grounded in real-world evidence.

Picis surgical patient management software seamlessly integrates data from various devices throughout the perioperative suite, enabling healthcare professionals to identify trends and insights that enhance patient flow while ensuring personalized care. This technology transforms hospitals into a cohesive care network connected by an evolving patient record, regardless of whether the patient arrives with an existing record or begins anew. Staff members gain immediate access to essential information, including resources, procedures, preferences, and medical histories, spanning from the physician's office to the recovery room. With responsive support from a clinical solutions partner that understands the needs of healthcare providers, the software is built on intuitive systems crafted by practitioners for practitioners. The Picis team is comprised of individuals who have firsthand experience in clinical settings, ensuring they can provide valuable insights and support. This unique approach guarantees that every aspect of the patient's journey, including services rendered and resources utilized, is automatically documented, allowing for a comprehensive overview of care delivered. By utilizing Picis, healthcare facilities can significantly enhance operational efficiency and ultimately improve patient outcomes.

Cleerly is a pioneering digital health organization that is revolutionizing how healthcare professionals manage heart disease. Our innovative clinical technologies are designed to enable clinicians to detect and accurately characterize atherosclerosis at an earlier stage, allowing for the development of customized and potentially life-saving treatment strategies for patients throughout their healthcare journey. Rather than relying on indirect indicators like risk factors or symptoms, we focus on measuring atherosclerosis directly, which is the accumulation of plaque in the arteries of the heart. By utilizing our AI-driven digital care pathways, we provide streamlined, rapid, and precise diagnostics and reporting that cater to the needs of all stakeholders, leading to enhanced clinical and financial results. Cleerly equips healthcare providers to transcend conventional assessments of heart disease by thoroughly analyzing, characterizing, and quantifying various plaque types. This advanced approach enables clinicians to better assess a patient's likelihood of experiencing a heart attack and to formulate effective treatment plans that aim to enhance overall heart health, ultimately fostering improved patient outcomes and quality of care.

Transform your healthcare experience with the revolutionary Soliton® AI, which is powered by 30,000 evidence-based rules and advanced machine learning techniques. By automating various healthcare and care management functions, Soliton® equips you with the tools necessary to thrive in a value-based care environment, offering unmatched capabilities. It efficiently analyzes vast amounts of patient data in real-time, leading to enhancements in both clinical outcomes and financial performance, while also supporting a range of Alternative Payment Models (APMs). The solution boosts the effectiveness of telehealth by forecasting billable codes during patient interactions and predicting future healthcare costs through sophisticated risk stratification models. Furthermore, it provides timely clinical decision support to assist in managing intricate patient populations. Soliton® optimizes the patient journey, facilitating seamless transitions from acute to post-acute care through AI-driven care coordination. Moreover, it identifies care gaps, uncovers service and coding opportunities, and generates tailored patient assessments and personalized care plans, while also enabling the creation of custom cohorts for targeted interventions. As a result, Soliton® not only enhances operational efficiency but also elevates the overall quality of patient care.

InformAI specializes in artificial intelligence solutions designed to enhance medical diagnostics at the point-of-care and boost the efficiency of radiologists. Our advanced AI-driven image classifiers and predictions related to patient outcomes are developed in collaboration with the Texas Medical Center, which is the largest medical center complex globally. Through partnerships with esteemed healthcare organizations, prominent physician associations, and top medical imaging firms, InformAI is revolutionizing healthcare delivery. Our team is made up of experts in the fields of healthcare, medicine, and artificial intelligence, working together to create innovations that lead to better patient results. One of our notable products, the InformAI Sinus Image Classifier, utilizes a 3D convolutional neural network (CNN) and is trained on a comprehensive library of 6 million radiology-validated 3D CT-scan images, showcasing our commitment to leveraging cutting-edge technology in the medical field. This approach not only enhances diagnostic accuracy but also contributes to more timely and effective patient care.

The Care Management Suite represents a comprehensive, data-informed solution for managing care, featuring a suite of tools and processes designed to enhance visibility across the entire spectrum of high-risk and at-risk patient populations. By enabling more efficient and patient-focused workflows, the suite aims to elevate the quality of care delivered while simultaneously lowering overall healthcare costs. Through the use of data analytics, the Care Management Suite identifies areas for improvement throughout the care process, thus driving better clinical, operational, and financial results. This solution is comprised of three key applications: Population Builder™: Stratification Module, Population Care Workflow, and Population Care Insights, each playing a vital role in the care management process. The suite offers a cohesive, end-to-end workflow that encompasses everything from patient enrollment and ongoing care management to patient record-keeping and collaboration among care team members, ultimately saving time and enhancing the standard of care delivered. Additionally, its analytics-driven Data Operating System platform consolidates various claims and electronic medical record data, creating a holistic view of each patient. By leveraging these insights, healthcare providers can make more informed decisions aimed at improving patient outcomes.

Eon Patient Management (EPM) is a cutting-edge platform aimed at the intelligent identification, tracking, and management of incidental findings across various disease categories. Leveraging a specialized AI engine, EPM meticulously analyzes reports dictated by radiologists to extract pertinent information with an impressive accuracy rate of 98.3%, thereby removing the necessity for additional expert reviews. The platform autonomously creates care plans and referrals that are guided by established clinical guidelines, which enhances the efficiency of programs and allows for large-scale in-network referrals. Additionally, EPM continuously tracks patient progress, making real-time adjustments to care and communication strategies to guarantee that follow-ups occur promptly. With its ability to integrate fluidly with primary electronic health record systems like Epic and Cerner, EPM facilitates bi-directional data exchange that supports holistic patient management. Furthermore, its comprehensive reporting features deliver valuable insights into operational, clinical, and financial metrics, paving the way for ongoing optimization of programs. This innovative approach not only improves patient outcomes but also promotes a more streamlined healthcare delivery system.

Paige's offerings have the potential to revolutionize the practice of pathologists by instilling greater certainty in diagnoses. The company is committed to pioneering a new era of clinical tools and predictive assessments that empower pathologists while redefining the field of oncology. With its innovative AI solutions, Paige paves the way for the future of pathology. The Paige Platform serves as a comprehensive, secure solution that ensures interoperability with laboratory information systems (LIS), integrates multiple scanners, offers cloud storage, facilitates case management, enables image review through FullFocus®, and incorporates advanced AI applications. The Paige Prostate suite of AI tools is specifically designed to aid pathologists in identifying suspicious areas, grading and quantifying tissue samples, and assessing perineural invasion (PNI) in prostate needle core biopsies. Similarly, the Paige Breast suite of AI applications supports pathologists in evaluating breast cancer by enabling the identification of malignancies in breast biopsies and the detection of metastases in lymph nodes associated with breast tissue. Collectively, these advancements not only enhance diagnostic accuracy but also improve patient outcomes in oncology.

Microsoft Cloud for Healthcare serves as an all-encompassing platform aimed at revolutionizing the healthcare sector by utilizing AI-driven solutions, integrating data, and ensuring secure, interconnected experiences. This platform assists healthcare providers, payors, and life sciences entities in enhancing patient care, optimizing operations, and bolstering research efforts. It provides resources for protecting confidential information, streamlining clinical processes, and fostering better patient engagement. By harnessing actionable insights derived from integrated clinical and operational data, Microsoft Cloud for Healthcare empowers organizations in the healthcare field to achieve favorable results, boost efficiency, and lower expenses. Ultimately, this innovative platform is pivotal in shaping the future of healthcare delivery.

Microsoft's Dragon Copilot represents a sophisticated AI-powered tool aimed at optimizing clinical processes through the automation of documentation, thereby alleviating administrative pressures. By seamlessly integrating with the Microsoft Cloud for Healthcare, it assists healthcare professionals in efficiently generating precise documentation based on interactions between patients and clinicians. This innovative solution accommodates various languages and retains functionality without internet access, enabling the collection of patient information and its transformation into notes tailored to specific medical specialties. Additionally, Dragon Copilot harnesses AI technology to propose enhancements for clinical interactions, automatically completes orders, and enables clinicians to search through notes and retrieve medical data, ultimately enhancing both operational efficiency and the quality of patient care. With its ability to adapt to the needs of healthcare providers, Dragon Copilot is poised to significantly revolutionize the way clinical documentation is handled.

Trovo assistants utilize specialized models and tailored workflows to ensure that healthcare practices can quickly adapt and thrive. Our goal is to support physicians in enhancing patient care and boosting operational efficiency. By integrating AI-driven assistants with the expertise of a multidisciplinary care team, we enable practices to broaden their horizons. Trovo Health's advanced platform, supported by skilled professionals from various fields, empowers healthcare providers to extend their services with ease. By leveraging specialized workflow technology along with the knowledge of expert team members, providers can introduce new services for patients, enhance outcomes, and streamline their operations. The company has assembled a dedicated group of clinicians and technology experts to realize its ambitious vision. With the new funding, Trovo aims to further enhance its technology platform, expand clinical operations, and strengthen its leadership team. The innovative platform developed by Trovo tackles some of the most pressing challenges faced in care delivery and operational processes, setting a new standard for healthcare solutions. Ultimately, Trovo is committed to revolutionizing healthcare services through advanced technology and collaborative care.

By leveraging visual analytics through TIBCO Spotfire®, PerkinElmer Signals Translational offers a comprehensive suite of tools designed to harmonize, manage, search, aggregate, and analyze extensive datasets consistently for translational research, all while ensuring scalability. This platform, driven by TIBCO Spotfire®, supports precision medicine initiatives by providing an unparalleled solution for biomarker discovery and patient stratification. The Linear Mixed Effect App (LME) within Signals Translational empowers researchers to evaluate the influence of various factors on specific phenotypes, allowing for adjustments related to random variables during analysis. Furthermore, it enables the identification of genes significantly affecting cancer stage progression, irrespective of patient origins. Notably, the LME models excel at addressing issues such as missing values and outliers, making them a robust choice for discovering potential biomarkers. Consequently, the integration of these advanced analytics tools enhances the efficacy of translational research in identifying key biomarkers that can lead to more personalized treatment approaches.